These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 14346763)

  • 21. Glucose, insulin and glucagon in the diabetic goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1976 Nov; 8(6):419-26. PubMed ID: 1002101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ON QUANTITATIVE STUDIES OF THE GLYCOGEN CONTENT OF THE LIVER IN HEALTHY AND DISEASED SUBJECTS. 3. ACTION MECHANISM OF GLUCAGON].
    BERINGER A; THALER H
    Wien Med Wochenschr; 1965 Feb; 115():105-7. PubMed ID: 14260959
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon.
    Lefebvre PJ; Luyckx AS; Lecomte MJ
    Horm Metab Res; 1976; Suppl 6():91-8. PubMed ID: 1278843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LIPOATROPHIC DIABETES. I. STUDIES CONCERNING ENDOCRINE FUNCTION AND CARBOHYDRATE METABOLISM.
    RUVALCABA RH; SAMOLS E; KELLEY VC
    Am J Dis Child; 1965 Apr; 109():279-86. PubMed ID: 14261005
    [No Abstract]   [Full Text] [Related]  

  • 26. [An evaluation of insulin requirement of diabetic patients by glucagon test].
    Kunihiro K
    Fukuoka Igaku Zasshi; 1987 Apr; 78(4):150-63. PubMed ID: 3301604
    [No Abstract]   [Full Text] [Related]  

  • 27. Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses.
    Manell E; Hedenqvist P; Svensson A; Jensen-Waern M
    PLoS One; 2016; 11(2):e0148896. PubMed ID: 26859145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Functional examination of glycoregulation].
    DEROT M; DOUSSET A
    Vie Med; 1963 May; 44():21-40. PubMed ID: 14027144
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE DIAPHROESIS TEST WITH INTRAVENOUS INSULIN IN THE AGED. II. COMPARISON WITH THE GLUCOSE TOLERANCE CURVE, THE PREDNISONE GLYCOSURIA TEST AND THE RASTINON TEST].
    BRONZINI A; GATTI A; MICHETTI A
    G Gerontol; 1964 May; 12():637-46. PubMed ID: 14195476
    [No Abstract]   [Full Text] [Related]  

  • 31. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH; Fajans SS; Smith MJ; Polonsky KS; Bell GI; Halter JB
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [GLUCOSE METABOLISM IN PROGRESSIVE DUCHENNE MYOPATHY].
    HERSCHBERG AD; COIRAULT R; GIBOUDEAU J
    Ann Endocrinol (Paris); 1964; 25():447-53. PubMed ID: 14177480
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of glucose, glucagon and standard meal-induced insulin release in patients with newly onset non-insulin-dependent diabetes mellitus.
    Tai WH; Jap TS; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Nov; 42(5):353-8. PubMed ID: 3076501
    [No Abstract]   [Full Text] [Related]  

  • 35. [MODIFICATIONS OF THE INSULO-PANCREATIC FUNCTIONAL ACTIVITY BY PARASYMPATHOLYTIC PHARMACOLOGIC EFFECT IN ESSENTIAL OBESITY].
    RODARI T; MAGGI G; FRATINO P
    Arch Sci Med (Torino); 1964 Feb; 117():78-94. PubMed ID: 14138216
    [No Abstract]   [Full Text] [Related]  

  • 36. RELEASE OF INSULIN-LIKE ACTIVITY FROM SERUM OF NORMAL SUBJECTS AND DIABETIC PATIENTS.
    POWER L; LUCAS C; CONN JW
    Metabolism; 1965 Feb; 14():110-4. PubMed ID: 14261395
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
    Wang Q; Brubaker PL
    Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A report on a case of association of diabetes mellitus and hyperthyroidism with no deterioration of diabetic control-with special regard to serial changes in glucose tolerance and glucoregulatory hormones.
    Yamaguchi K; Fukushima H; Uzawa H
    Fukuoka Igaku Zasshi; 1982 May; 73(5):272-80. PubMed ID: 6751968
    [No Abstract]   [Full Text] [Related]  

  • 39. [The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)].
    Schatz H; Pfeiffer EF
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):485-92. PubMed ID: 818514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRITICAL FACTORS IN EXCESSIVE SERUM-INSULIN RESPONSE TO GLUCOSE. OBESITY IN MATURITY-ONSET DIABETES AND GROWTH HORMONE IN ACROMEGALY.
    KARAM JH; GRODSKY GM; PAVLATOS FC; FORSHAM PH
    Lancet; 1965 Feb; 1(7380):286-9. PubMed ID: 14247872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.